Cancer Pharmacology

The MSc in Cancer Pharmacology at the University of Bradford offers an in-depth exploration of the molecular mechanisms underlying cancer development and progression, with a focus on the pharmacological approaches used in the treatment and management of cancer. The programme is designed to equip students with comprehensive knowledge of cancer biology, pharmacology, and emerging therapeutic strategies, preparing them for careers in research, clinical practice, or the pharmaceutical industry. Students will engage with advanced topics such as targeted therapies, immunotherapies, drug design, and personalized medicine, gaining valuable insights into how drugs interact with biological systems to combat cancer effectively. The programme combines theoretical lectures, practical laboratory work, and project-based learning to develop both scientific understanding and hands-on skills. Additionally, students will examine current challenges in cancer treatment, including drug resistance and toxicity, and explore innovative solutions arising from recent research developments. The course benefits from the university’s strong links with healthcare providers and industry partners, providing opportunities for networking, internships, and collaborative projects. Graduates will be well-prepared to pursue further research or to work in clinical, pharmaceutical, or regulatory roles within the oncology field. With a flexible structure, the programme caters to students from various backgrounds, including biomedical sciences, pharmacy, and related disciplines, enabling a multidisciplinary approach to solving complex problems in cancer therapy. Overall, the MSc in Cancer Pharmacology combines cutting-edge science with practical application, fostering the next generation of scientists and professionals dedicated to improving cancer treatment outcomes worldwide.

The programme has a central core of modules in the first semester which are designed to train you in widely used laboratory techniques, research methodology, and in critical analysis and thinking. The 20-credit Practical Skills in Research module is designed around common laboratory techniques and skills including ELISA, flow cytometry, Western Blot, statistical analysis etc. You will have a series of workshops to learn these techniques with a lab session where you carry out the procedure.

In the 20-credit Critical Appraisal module, you are assigned a topic under the supervision of one of our academics and are asked to write a 5000-word critical review. In this module, you will receive a wide range of training and advice on scientific writing, compiling scientific data, data analysis, scientific presentation etc.

The remaining 20-credit first semester module, Molecular Basis of Cancer and Cancer Therapy, provides you with the core academic knowledge required in this field. During the first semester, you will gain knowledge of the breadth of cutting edge research at ICT and either choose or suggest a research project plan.

In semester 2 you will study 20-credit Preclinical Models for Drug Evaluation module designed around protocols and techniques used in the in vitro and in vivo evaluation of drug potency and 20 credit Cancer Pharmacology module designed around recent advances in the development of cancer therapeutics. The remaining 20-credit module can be chosen from a list of options to reflect your career aspirations.

In semester 3 you will join research laboratories within the ICT, to undertake your 60-credit Research Project module. During this time, you are trained in specialist laboratory techniques and conduct your chosen research.

All module information is for 2019 entry, and is subject to change.

To be admitted to the programme, applicants must have an undergraduate Honours qualification (minimum 2: 2) or equivalent in a scientific discipline, usually within chemistry, biology, pharmacy, biomedicine, or related fields. Candidates who do not meet these entry criteria, but who can show relevant experience may also be considered.

For North American students a GPA of normally 2.0 and above (on a scale of 4.0), or an equivalent, is required.

Fees for 2019 entry listed below.

Home/EU: £8,160 per year

International: £18,940 per year

The MSc in Cancer Pharmacology at the University of Bradford offers students an in-depth understanding of the molecular mechanisms underlying cancer development and progression, with a particular focus on the pharmacological approaches used to treat cancer. The programme is designed to equip students with a comprehensive knowledge of current cancer therapies, emerging pharmaceutical interventions, and the research techniques necessary for advancing cancer treatment. It combines theoretical learning with practical laboratory work, allowing students to develop essential skills in drug development, pharmacokinetics, and pharmacodynamics, as well as the analysis of biological data.

Throughout the course, students explore topics such as cancer biology, targeted therapies, chemotherapy, immunotherapy, and the role of genetics in cancer. Emphasis is placed on understanding how different drugs interact with cancer cells, mechanisms of drug resistance, and the challenges associated with optimizing cancer treatments. The programme promotes critical thinking and encourages students to engage in independent research projects. These projects may involve laboratory experiments, data analysis, or literature reviews, providing valuable experience in scientific research processes.

The course is suitable for those interested in pursuing careers in pharmaceutical industries, research institutions, or clinical settings related to oncology. It aims to produce graduates who are well-prepared to contribute to the development of new cancer therapies or to undertake further research at PhD levels. Teaching staff are experienced researchers and clinicians who utilize innovative teaching methods, including seminars, tutorials, and laboratory classes.

The University of Bradford also offers excellent research facilities and links with local, national, and international health organizations, providing students opportunities for networking and internships. The programme typically spans one year full-time, with options for part-time study. Entry requirements generally include a relevant undergraduate degree in biomedical sciences, pharmacy, or a related discipline. Funding options and scholarships may be available for eligible students. Overall, the MSc in Cancer Pharmacology at Bradford aims to prepare students for a successful career in the rapidly evolving field of cancer research and treatment, fostering a deep understanding of pharmacological principles and their application in fighting cancer.